March 9, 2021, from 9:00 am - 12:30 pm ET, prior to HTRS/NASTH 2021
Our biennial colloquium on uterine hemostatic disorders will convene leading faculty/researchers/clinicians to review our current understanding of the science and evidence-based practice related to the diagnosis and clinical management of abnormal uterine hemostasis.
The educational goals for this meeting are:
- Convene top experts in the fields of Obstetrics/Gynecology and in Hematology, who are working in uterine hemostasis and blood disorders in women and girls.
- Review the state of the science with respect to normal uterine hemostasis.
- Recognize the range of complications related to abnormal uterine hemostasis.
- Describe and review the epidemiology and variability in phenotype regarding women with hemophilia.
- Examine the full range of options for achieving uterine hemostasis in women with acute abnormal uterine bleeding, postpartum hemorrhage, and bleeding and clotting disorders including thrombotic microangiopathies.
- Develop and disseminate a summary of what was discussed regarding the state-of-the- science in hemostatic disorders in women and girls and identify research gaps.
- Effectively disseminate best practices in the care of women with abnormal uterine bleeding, hemophilia, postpartum hemorrhage, and thrombotic microangiopathies
- Describe, and underscore for target healthcare providers, the intersection of obstetrics/gynecology and hematology in the optimal care of these women and develop mechanisms for facilitating the collaboration of these specialties
Target Audience: Hematologists, Obstetricians, Gynecologists, Clinicians, Researchers, Medical Students, Trainees, and Junior Faculty, Nurses and Nurse Practitioners
Please note that you will need to register for HTRS/NASTH 2021 in order to participate in the Hemostatic Disorders Colloquium. Registration for both events may be completed at the same time.
Date: Tuesday, March 9, 2021, from 9:00 am - 12:30 pm ET
CME/CE Accredited by: Cine-Med